March 21 (Reuters) - Ambu A/S AMBUb.CO :
* PRESENTS UPDATED MARKET POTENTIAL ASSUMPTIONS AT ITS CAPITAL MARKETS DAY 2023, AND
SPECIFIES
LONG-TERM FINANCIAL TARGETS
* MAINTAINS FY 2022/2023 FINANCIAL GUIDANCE
* SPECIFIES ITS LONG-TERM FINANCIAL TARGETS
* EXPECTS A 5-YEAR ORGANIC REVENUE CAGR (2022/23-2027/28) OF >10%
* COMPANY EXPECTS AN EBIT MARGIN (BEFORE SPECIAL ITEMS) >10% WITHIN NEXT TWO YEARS, WITH A
5-YEAR
TARGET OF AROUND 20% (2027/28)
* LONG TERM GUIDANCE: REVENUE GROWTH IN ENDOSCOPY SOLUTIONS OF 15-20%, ANAESTHESIA AND
PATIENT
MONITORING COMBINED OF 2-4%, RESPECTIVELY
* AIMS TO BECOME A POSITIVE CASH FLOW (FCF) GENERATING COMPANY IN 2023/24
* MAY CONSIDER TO RAISE CAPITAL EQUAL TO AROUND 5% OF ITS B-SHARES OUTSTANDING, SUBJECT TO
MARKET
CONDITIONS AND INVESTOR SUPPORT
Source text for Eikon: ID:nGNEc5d4Yc
Further company coverage: AMBUb.CO
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))